baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Pieris Pharmaceuticals/ US7207952026 /

06/06/2024 18:36:04	Chg. -	Volume	Bid-	Ask-	High	Low
10.29USD	-	1 Turnover: 10.29	-Bid Size: -	-Ask Size: -	10.29	10.29

GlobeNewswire 05/01 Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

GlobeNewswire 28/01/2022 HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

GlobeNewswire 11/11/2021 Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors

GlobeNewswire 23/08/2021 Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member

GlobeNewswire 18/03/2021 Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day

GlobeNewswire 02/11/2020 Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer

GlobeNewswire 09/07/2020 ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer

GlobeNewswire 21/06/2019 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market 2019

GlobeNewswire 10/04/2019 New Research Coverage Highlights Fortive, Pieris Pharmaceuticals, CEVA, ManTech International, Cerus...

GlobeNewswire 26/02/2019 Factors of Influence in 2019, Key Indicators and Opportunity within Conagra Brands, Pieris Pharmaceu...

GlobeNewswire 17/12/2018 Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...

GlobeNewswire 07/11/2018 Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire 31/10/2018 Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, ...

GlobeNewswire 25/09/2018 Pieris Pharmaceuticals to Present at Investor Conferences in October

GlobeNewswire 14/09/2018 Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at ...

GlobeNewswire 10/09/2018 Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors

GlobeNewswire 04/09/2018 Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Pl...

GlobeNewswire 30/08/2018 Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

GlobeNewswire 15/08/2018 New Research Coverage Highlights Cincinnati Bell, BioCryst Pharmaceuticals, Shutterstock, Kopin, Lan...

GlobeNewswire 10/08/2018 Novel Drugs and Smart Devices for Respiratory Disorders, 2030 - Focus on Asthma, COPD and Cystic Fib...

GlobeNewswire 09/08/2018 Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire 08/08/2018 Pieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference

GlobeNewswire 01/08/2018 Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2...

GlobeNewswire 31/05/2018 Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

GlobeNewswire 10/05/2018 Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

Pieris Pharmaceuticals/ US7207952026 /

If you wish to receive reply to your feedback, please provide your email address.